HIV incidence among injecting drug users in New York City syringe-exchange programmes (Q30233828)

11 June 2017

0 references

HIV incidence among injecting drug users in New York City syringe-exchange programmes (English)

1 reference

ORCID Public Data File 2021

11 June 2017

1 reference

1 reference

Don C Des Jarlais

1

object named as

D C Des Jarlais

1 reference

11 June 2017

8

S R Friedman

1 reference

11 June 2017

M Marmor

2

1 reference

11 June 2017

D Paone

3

1 reference

11 June 2017

S Titus

4

1 reference

11 June 2017

Q Shi

5

1 reference

11 June 2017

T Perlis

6

1 reference

11 June 2017

B Jose

7

1 reference

11 June 2017

language of work or name

English

0 references

publication date

1 October 1996

1 reference

11 June 2017

1 reference

11 June 2017

volume

348

1 reference

11 June 2017

issue

9033

1 reference

11 June 2017

page(s)

987-991

1 reference

Syringe-exchange programmes for injecting drug users

11 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2902536-6

7 January 2021

HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2902536-6

7 January 2021

The New York Needle Trial: the politics of public health in the age of AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2902536-6

7 January 2021

Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2902536-6

7 January 2021

The challenge of meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2902536-6

7 January 2021

HIV surveillance by testing saliva

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2902536-6

7 January 2021

Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. The National AIDS Research Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2902536-6

7 January 2021

Exposure factors for HIV-1 infection among heterosexual drug abusers in New Jersey treatment programs.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2902536-6

7 January 2021

Duration of human immunodeficiency virus infection before detection of antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2902536-6

7 January 2021

Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2902536-6

7 January 2021

Decline in HIV-1 seroprevalence and low seroconversion rate among injecting drug users at a methadone maintenance program in New York City

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2902536-6

7 January 2021

The estimated prevalence and incidence of HIV in 96 large US metropolitan areas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2902536-6

7 January 2021

10.1016/S0140-6736(96)02536-6

Identifiers

DOI

1 reference

11 June 2017

1 reference